1.880USD-0.53%Mkt Cap: 103.37M USDP/E: —Last update: 2026-06-01
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap103.37M USD
Enterprise Value-56.17M USD
Revenue (TTM)16.58M USD
Gross Profit8.01M USD
Net Income (TTM)-73.60M USD
Revenue/Share0.2890 USD
Last Price1.880 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees124
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.91
PEG—
EV/EBITDA0.78
EV/Revenue-3.39
P/S6.20
P/B0.41
EPS (TTM)-1.24
EPS (Forward)-0.98
52W Range
1.65030% of range2.410
52W High2.410 USD
52W Low1.650 USD
Profitability
Gross Margin49.67%
Oper. Margin-413.83%
EBITDA Margin0.00%
Profit Margin-456.60%
ROE-28.38%
ROA-24.86%
Growth
Revenue Growth5.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.45M USD
CapEx (TTM)1.80M USD
FCF Margin-166.78%
FCF Yield-26.75%
Net Debt-162.24M USD
Net Debt/EBITDA2.26
Balance Sheet
Debt/Equity0.09
Current Ratio12.84
Quick Ratio12.23
Book Value/Sh4.612 USD
Cash/Share3.295 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)4.000 USD
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.54.98M
Float41.54M
Insiders10.03%
Institutions51.02%
Short Interest
Short Ratio1.1d
Short % Float0.93%
Short % Out.0.82%
Shares Short453.02K
Short (prev mo.)432.59K
Technical
SMA 501.823 (+3.2%)
SMA 2001.954 (-3.8%)
Beta1.64
S&P 52W Chg27.70%
Avg Vol (30d)356.56K
Avg Vol (10d)284.51K
Technical Indicators
RSI (14)57.0
MACD-0.0044
MACD Signal-0.0191
MACD Hist.+0.0147
BB Upper2.011 USD
BB Middle1.824 USD
BB Lower1.638 USD
BB Width20.43%
ATR (14)0.0706 USD
Vol Ratio (20d)0.24x